Taila Bindu Pariksha, an ancient method of urine examination for ascertaining the prognosis of diseases, was very popular in the medieval period, the use of which became obsolete after 17th Century AD. Technique of this test is very crude and there are chances of variations in the observations. To revive this technique, it is necessary that the methodology of this test should be standardized so that the observations could be reproducible. To standardize the technique, apparently healthy volunteers were selected and various parameters were standardized for doing this test, i.e., shape and size of Patra (testing containers), volume of the urine, size of the oil drop, height of the oil drop from the surface of urine, variety of sesame oil, etc., Based on the literature, the parameters were changed one by one and observations were noted down. The whole method was recorded in the form of video clips for proper evaluation. The parameters standardized on the basis of observations can be considered as standard to be referred in future studies.

Background: Since the novel SARS-CoV-2 has been detected and the ensuing pandemic, the search for a cure or prevention has been the only target of the medical fraternity. As the second wave racked havoc, vaccines seemed to be the only viable option to stop this global surge. World Health Organization (WHO) and subsequently the Government of India have issued emergency use authorization to two vaccines. Our study aims to estimate the prevalence of the anti-SARS-CoV-2 antibodies and identify predictors of antibody titers in vaccinated healthcare workers in VIMSAR, Burla. Methods: This is a part of the ongoing, repeated cross-sectional study. Participants were enrolled well above the sample size (322) to increase precision. Two rounds of the survey were conducted and are being reported. Serum IgG antibodies against spike protein of SARS-CoV-2 were estimated using Elecsys ® anti-SARS-CoV-2S is an immunoassay by ECLIA-based Cobas e411 analyzer. Univariate and multivariate regression were used in statistical analysis. Results: Our results show that 95.1% and 99.5% of the vaccinated individuals have developed antispike protein antibodies after the first and second doses, respectively. Previous COVID-19 infection was significantly correlated with antibody production, and age was negatively correlated. No difference was reported for sex, occupation, and diabetes. Conclusion: Our interim analysis report is coherent with the available literature and research regarding the high efficacy of the COVID-19 vaccine as far as seroconversion is concerned.

No abstract